WHO ICTRP trial
An exploratory Phase 2 study to evaluate the Safety and Efficacy of CRN00808 for…
EUCTR2018-002230-20-SK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-002230-20-SK |
|---|---|
| Public title | An exploratory Phase 2 study to evaluate the Safety and Efficacy of CRN00808 for the treatment of acromegaly |
| Scientific title | An open label exploratory study to evaluate the safety, pharmacokinetics and efficacy of CRN00808 in patients with acromegaly treated with somatostatin analogue based treatment regimens (ACROBAT EDGE) - ACROBAT EDGE |
| Primary sponsor | Crinetics Pharmaceuticals, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Serbia;Hungary;Slovakia;Greece;Poland;Romania;Australia;Germany;United Kingdom;Italy |
| Conditions | Acromegaly MedDRA version: 20.0 Level: PT Classification code 10000599 Term: Acromegaly System Organ Class: 10014698 - Endocrine disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19] |
| Interventions | Product Name: CRN00808 Product Code: CRN00808 Pharmaceutical Form: Capsule INN or Proposed INN: not assigned yet Current Sponsor code: CRN00808.HCl Other descriptive name: CRN00808 Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Sep 14, 2018 |
| Target size | 45 |
| Secondary IDs | CRN00808-03;NCT03729555;2018-002230-20-HU |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: